17 Moreover, other trials as the SUSTAIN-6 trial showed that semaglutide, another GLP-1RA also reduced the risk of MACE by 26% and non-fatal stroke by 39% in patients with T2DM
J Clin Endocrinol Metab 94(6):18431852
Zepbound (tirzepatide): Approved for weight management in people with obesity or weight-related health issues
The choice often boils down to your preferencemany opt for the convenience of a daily pill, while others like the simplicity of once-weekly injections
Abushanab D, Marquina C, Morton JI, et al
Furthermore, the relevance of a Grx(SSR) intermediate and an attack by GSH at the glutaredoxin sulfur atom according to monothiol mechanism (i) were postulated for the reduction of the non-glutathione disulfide bond of the HMA4 domain 60